1. Home
  2. Analysis
  3. Makena
  4. Nasopharyngitis

Makena and Nasopharyngitis - a phase IV clinical study of FDA data

Summary:

Nasopharyngitis is reported as a side effect among people who take Makena (hydroxyprogesterone caproate), especially for people who are female, 20-29 old, have been taking the drug for 1 - 6 months also take Claritin, and have Premature delivery.

The phase IV clinical study analyzes which people have Nasopharyngitis when taking Makena. It is created by eHealthMe based on reports of 24,287 people who have side effects when taking Makena from the FDA, and is updated regularly.

What is Makena?

Makena has active ingredients of hydroxyprogesterone caproate. eHealthMe is studying from 24,292 Makena users. Check the latest studies of Makena.

What is Nasopharyngitis?

Nasopharyngitis (inflammation of the nasopharynx) is found to be associated with 2,433 drugs and 2,241 conditions by eHealthMe. Check the latest studies of Nasopharyngitis.

On Aug, 01, 2026

24,287 people reported to have side effects when taking Makena.
Among them, 38 people (0.16%) have Nasopharyngitis.

Could Makena cause Nasopharyngitis?

Among these 38 people:

How long have people been on Makena when they have Nasopharyngitis? *

  • < 1 month: 22.22 %
  • 1 - 6 months: 66.67 %
  • 6 - 12 months: 11.11 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Nasopharyngitis when taking Makena? *

  • female: 87.5 %
  • male: 12.5 %

What is the age of people who have Nasopharyngitis when taking Makena? *

  • 0-1: 15.38 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 76.92 %
  • 30-39: 7.69 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

What are other drugs people take besides Makena? *

  1. Vitamin D: 1 person, 2.63%
  2. Vitamin C: 1 person, 2.63%
  3. Pepcid Ac: 1 person, 2.63%
  4. Flonase: 1 person, 2.63%
  5. Claritin: 1 person, 2.63%

What are other side effects people have besides Nasopharyngitis? *

  1. Injection Site Pain: 4 people, 10.53%
  2. Injection Site Pruritus (severe itching at injection site): 4 people, 10.53%
  3. Headache (pain in head): 4 people, 10.53%
  4. Fatigue (feeling of tiredness): 4 people, 10.53%
  5. Peripheral Swelling: 3 people, 7.89%
  6. Cough: 3 people, 7.89%
  7. Nausea (feeling of having an urge to vomit): 3 people, 7.89%
  8. Dizziness: 3 people, 7.89%
  9. Rashes (redness): 3 people, 7.89%
  10. Injection Site Mass: 3 people, 7.89%

What are the existing conditions these people have? *

  1. Premature Delivery: 21 people, 55.26%
  2. Premature Labor: 1 person, 2.63%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 2.63%
  4. Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 1 person, 2.63%
  5. Abortion Spontaneous (naturally occurring miscarriage): 1 person, 2.63%

* Approximation only. Some reports may have incomplete information.

Do you take Makena and have Nasopharyngitis?

- Check whether Nasopharyngitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Makena:

Nasopharyngitis treatments and more:

How severe was Nasopharyngitis and when was it recovered:

Expand to all the drugs that have ingredients of hydroxyprogesterone caproate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Makena:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nasopharyngitis:

Browse all the conditions that are associated with Nasopharyngitis:

How the study uses the data?

The study uses data from the FDA. It is based on hydroxyprogesterone caproate (the active ingredients of Makena) and Makena (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.